Human mesenchymal stem cells suppress allogeneic T cell responses in vitro:: Implications for allogeneic transplantation.

被引：0
|
作者：
Klyushnenkova, E [1 ]
Mosca, JD [1 ]
McIntosh, KR [1 ]
机构：
[1] Osiris Therapeut Inc, Baltimore, MD USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2652
引用
收藏
页码：642A / 642A
页数：1
相关论文
共 50 条
  • [31] Ursodiol for the prevention of hepatic complications in allogeneic stem cell transplantation.
    Ruutu, T
    Eriksson, B
    Remes, K
    Volin, L
    Remberger, M
    Parkkali, T
    Juvonen, E
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 1999, 23 : S224 - S224
  • [32] Alloimmune heptitis following allogeneic peripheral stem cell transplantation.
    Habib, S
    Nalesnik, MA
    Shakil, OA
    Ahmed, J
    BuchBarker, D
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 56 - 56
  • [33] Costs of complications after allogeneic myeloablative stem cell transplantation.
    Saito, Akiko M.
    Cutler, Corey
    Zahrieh, David
    Ho, Vincent T.
    Alyea, Edwin P.
    Soiffer, Robert J.
    Antin, Joseph H.
    Lee, Stephanie J.
    BLOOD, 2006, 108 (11) : 844A - 844A
  • [34] Valganciclovir in the prevention of cytomegalovirus following allogeneic stem cell transplantation.
    Magalhaes-Silverma, Margarida
    Parrott, Karen
    Carter, Thomas
    Leopold, Christina
    Raymond, Hohl
    Roger, Gingrich
    BLOOD, 2006, 108 (11) : 807A - 807A
  • [35] Toll like receptors in allogeneic hematopoietic stem cell transplantation.
    Waghmare, AA
    Hubbard, V
    van den Brink, M
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S129 - S129
  • [36] Safety of voriconazole after autologous and allogeneic stem cell transplantation.
    Restrepo, MH
    Langston, AA
    Shayani, S
    Waller, EK
    Lonial, S
    BLOOD, 2003, 102 (11) : 454B - 454B
  • [37] Ursodiol for the prevention of hepatic complications in allogeneic stem cell transplantation.
    Ruutu, T
    Eriksson, B
    Remes, K
    Juvonen, E
    Volin, L
    Remberger, M
    Parkkali, T
    Hägglund, H
    Ringdén, O
    BLOOD, 1999, 94 (10) : 607A - 607A
  • [38] ABO incompatibility as a prognostic factor in allogeneic stem cell transplantation.
    Benjamin, RJ
    McGurk, S
    Raiston, M
    Churchill, WH
    Antin, JH
    TRANSFUSION, 1998, 38 (10) : 70S - 70S
  • [39] The efficacy and safety of second allogeneic hematopoietic stem cell transplantation.
    Toprak, Selami Kocak
    Korcalo, Ekin
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Gurman, Gunhan
    Beksac, Meral
    Ilhan, Osman
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Mesenchymal Stem Cells Suppress Cytotoxic Activity of Natural Killer Cells in Islet Cell Transplantation.
    Saeki, Y.
    Ishiyama, K.
    Hirata, F.
    Tanaka, Y.
    Ohdan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 239 - 239
12345